Wu Lingshuang, Choi Yong Mi, Omrane Mohyeddine, Chai Jiyao, Gao Shujuan, Thiam Abdou Rachid, Canals Daniel, Airola Michael V
bioRxiv. 2025 Sep 22:2025.09.22.677815. doi: 10.1101/2025.09.22.677815.
Hereditary spastic paraplegia subtype SPG54 is a genetic neurological disorder caused by mutations in the DDHD2 gene. Excessive lipid droplet accumulation is observed in the brains of SPG54 patients and DDHD2 knockout mice, consistent with DDHD2's reported neutral lipase activity. Here, we find recombinant human DDHD2 preferentially hydrolyzes diacylglycerol (DAG) over phospholipids, with a slight preference for DAG over triacylglycerol (TAG). DDHD2 also exhibits transacylase activity, which enables transfer of acyl chains from triacylglycerols to diacylglycerols and monoacylglycerols to remodel the acyl chains of triglycerides. A predicted hydrophobic amphipathic helix on DDHD2 is essential for lipid droplet binding in vitro and in cells, and its lack reduces the enzymatic activity and triglyceride acyl chain remodeling. Adipose triglyceride lipase (ATGL), but not hormone sensitive lipase (HSL), also has transacylation activity and can remodel triglyceride acyl chains, but to a lesser extent than DDHD2. Taken together, this provides evidence that DDHD2 is a neutral lipid lipase and transacylase whose broad specificity enables triglyceride acyl-chain remodeling.
Triglycerides (TAGs), the primary form of long-term energy storage, have acyl chain compositions crucial for diverse cellular processes. Lipases typically hydrolyze TAGs into free fatty acids. Here, we reveal a novel function for the neutral lipid lipase DDHD2: a transacylase activity. Instead of releasing fatty acids, DDHD2 transfers them between neutral lipids, altering TAG acyl chain composition. This transacylation requires the unique oil environment of lipid droplets (LDs), which excludes water from DDHD2's lipolytic active site, favoring transacylation over hydrolysis. DDHD2's lipase and transacylase activities enable TAG acyl-chain remodeling, demonstrating the possibility that a single enzyme can catalyze TAG cycling. This finding has implications for understanding lipid metabolism, LD dynamics, and specific motor neuron diseases implicating DDHD2.
遗传性痉挛性截瘫亚型SPG54是一种由DDHD2基因突变引起的遗传性神经疾病。在SPG54患者和DDHD2基因敲除小鼠的大脑中观察到脂质小滴过度积累,这与DDHD2报道的中性脂肪酶活性一致。在这里,我们发现重组人DDHD2对二酰基甘油(DAG)的水解优先于磷脂,对DAG的偏好略高于三酰基甘油(TAG)。DDHD2还表现出转酰基酶活性,能够将酰基链从三酰基甘油转移到二酰基甘油,以及从单酰基甘油转移,以重塑甘油三酯的酰基链。DDHD2上预测的疏水两性螺旋对于体外和细胞内脂质小滴的结合至关重要,缺乏该螺旋会降低酶活性和甘油三酯酰基链重塑。脂肪甘油三酯脂肪酶(ATGL)而非激素敏感脂肪酶(HSL)也具有转酰基活性,并且可以重塑甘油三酯酰基链,但程度低于DDHD2。综上所述,这证明DDHD2是一种中性脂质脂肪酶和转酰基酶,其广泛的特异性能够实现甘油三酯酰基链重塑。
甘油三酯(TAGs)是长期能量储存的主要形式,其酰基链组成对多种细胞过程至关重要。脂肪酶通常将TAGs水解为游离脂肪酸。在这里,我们揭示了中性脂质脂肪酶DDHD2的一种新功能:转酰基酶活性。DDHD2不是释放脂肪酸,而是在中性脂质之间转移它们,改变TAG的酰基链组成。这种转酰基作用需要脂质小滴(LDs)独特的油环境,该环境将水排除在DDHD2的脂解活性位点之外,有利于转酰基作用而非水解作用。DDHD2的脂肪酶和转酰基酶活性能够实现TAG酰基链重塑,证明了单一酶催化TAG循环的可能性。这一发现对于理解脂质代谢、LD动态以及涉及DDHD2的特定运动神经元疾病具有重要意义。